The U.S. Federal Food and Drug Administration ('FDA' or 'Agency') Commissioner Dr. Scott Gottlieb has used an FDA blog post to announce plans for a new digital health devices initiative, specifically the initiative's Digital Health Innovation Plan, which is intended to provide tools to the Agency that encourage device makers to be innovative and put resources into the development of new digital health devices. Diane Romza-Kutz of Thompson Coburn LLP describes what's known about the Plan so far in this July Digital Health Legal article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.